Literature DB >> 10375548

Cytotoxic T lymphocyte activation by cross-priming.

W R Heath1, F R Carbone.   

Abstract

Cross-priming represents the induction of cytotoxic T lymphocyte responses to exogenous, usually cell associated, antigens that are captured and re-presented on bone-marrow-derived antigen-presenting cells. For effective cross-priming, cytotoxic T lymphocytes require help from CD4(+) T cells, which mediate this help indirectly via modification of the antigen-presenting cell. Recent advances made in research into the cellular and molecular interactions required for cross-priming have greatly improved our understanding of the antigenic requirements for effective priming and have revealed a role for CD40 and its ligand in the provision of T cell help.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375548     DOI: 10.1016/s0952-7915(99)80050-8

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  19 in total

Review 1.  The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells.

Authors:  H Singh-Jasuja; N Hilf; H U Scherer; D Arnold-Schild; H G Rammensee; R E Toes; H Schild
Journal:  Cell Stress Chaperones       Date:  2000-11       Impact factor: 3.667

2.  Neutrophils sustain pathogenic CD8+ T cell responses in the heart.

Authors:  Nir Grabie; Dennis T Hsieh; Chiara Buono; Jason R Westrich; Jessica A Allen; Hong Pang; George Stavrakis; Andrew H Lichtman
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 3.  CD4 T cells in tumor immunity.

Authors:  Mara Gerloni; Maurizio Zanetti
Journal:  Springer Semin Immunopathol       Date:  2005-03-15

Review 4.  The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

Authors:  David A Reardon; Duane A Mitchell
Journal:  Semin Immunopathol       Date:  2017-01-30       Impact factor: 9.623

Review 5.  Immune recognition and rejection of allogeneic skin grafts.

Authors:  Gilles Benichou; Yohei Yamada; Seok-Hyun Yun; Charles Lin; Michael Fray; Georges Tocco
Journal:  Immunotherapy       Date:  2011-06       Impact factor: 4.196

6.  Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.

Authors:  K H Edelmann; C B Wilson
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 7.  DNA vaccines for HIV: challenges and opportunities.

Authors:  David A Hokey; David B Weiner
Journal:  Springer Semin Immunopathol       Date:  2006-10-10

8.  The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells.

Authors:  Kenny K Tran; Hong Shen
Journal:  Biomaterials       Date:  2008-12-16       Impact factor: 12.479

9.  The early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells.

Authors:  Scott N Mueller; Claerwen M Jones; Weisan Chen; Yoshihiro Kawaoka; Maria R Castrucci; William R Heath; Francis R Carbone
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Requirement of B cells for generating CD4+ T cell memory.

Authors:  Jason K Whitmire; Mary S Asano; Susan M Kaech; Surojit Sarkar; Lynn G Hannum; Mark J Shlomchik; Rafi Ahmed
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.